Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Erin Green

Role not yet determined Is this you? Add your title

Also affiliated: BC Cancer Agency (2012); Froedtert Hospital (2014–2022); Mercy Health System (2005); Sunnybrook Health Science Centre (2010); University Health Network (2014–2016); Mayo Clinic (2004–2008); Breast Cancer Research Foundation (2013); Medical College of Wisconsin (2021–2022); San Diego State University (2010–2019); North Central Cancer Treatment Group (2005); Institut Jules Bordet (2006); Princess Margaret Cancer Centre (2016); Health Net (2021–2022); University of California San Diego (2010–2019); Fred Hutch Cancer Center (2007); Cleveland Clinic Florida (2008); Mayo Clinic in Arizona (2005–2016); Mayo Clinic in Florida (2005); NRG Oncology (2009–2013); Sunnybrook Hospital (2010); California State University, Sacramento (2022); University of Rochester (2009); Southern States University (2015); St. John Fisher College (2007)

22 h-index 48 pubs 4,955 cited

  • Humans
  • Female
  • Male
  • Adult
  • Aged
  • Middle Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Magnetic Resonance Imaging
  • Reward
  • Brain Mapping
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Brain
  • Colonic Neoplasms
  • Disease-Free Survival

Biography and Research Information

OverviewAI-generated summary

Erin Green's research has focused on analyzing large patient datasets to evaluate cancer treatment efficacy and identify factors influencing outcomes. Her work includes examining disease-free survival and overall survival as primary endpoints in adjuvant colon cancer studies, drawing on individual patient data from extensive randomized trials. Green has investigated the impact of age on the efficacy of newer adjuvant therapies for patients with Stage II/III colon cancer, utilizing findings from the ACCENT database.

Her publications also address the safety and efficacy of specific chemotherapy regimens, such as oxaliplatin plus fluorouracil/leucovorin, particularly in elderly patient populations. Additionally, Green has explored the genetic markers associated with toxicity from fluorouracil-based regimens. Beyond cancer research, her work has touched upon behavioral science, including an investigation into altered sweet taste processing in diet soda drinkers.

Green holds an h-index of 22 with 48 total publications and over 4,955 citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Riley C. Lide and Rachel Moquin.

Metrics

  • h-index: 22
  • Publications: 48
  • Citations: 4,955

Selected Publications

  • Constructing a Validity Argument and Exploring Implications for the American Board of Anesthesiology’s Basic Examination (2025)
    Journal of Education in Perioperative Medicine DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

2 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics